Cost and Efficacy in Diabetes Medications

This chapter examines the impact of capitalism on the pharmaceutical industry, particularly focusing on the affordability and marketing of diabetes medications like insulin and terzepatide. It discusses challenges within the healthcare system, highlights recent advances in obesity and diabetes treatment, and emphasizes patient selection for emerging therapies. The chapter also explores the differences in health experiences among diabetes patients and advocates for strength training alongside medication use.